← Leaderboards
Louise Hecker
Fibronox, L.L.C.
$534,758
Attributed
$534,758
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $286.7K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$534,758 · 2
By mechanism
R41$534,758 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Therapeutic Target”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,314,676
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Therapeutic TargetBiotechnologyMyofibroblastTherapeutic DevelopmentPathologicOralFibrosisMouse ModelOxidative StressSmall Business Technology Transfer ResearchUniversitiesTissuesPathogenesisClinically RelevantExhibitsFda ApprovedCollaborationsMediatingCicatrixAntioxidantsCessation Of LifeDisease ProgressionCardiac MyocytesAnimal Model